Huang Xiaoxu, Zhang Yumeng, Jiang Yuxin, Li Tong, Yang Shiqi, Wang Yimin, Yu Bo, Zhou Minwen, Zhang Guanran, Zhao Xiaohuan, Sun Junran, Sun Xiaodong
Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.
National Clinical Research Center for Eye Diseases; Shanghai Key Laboratory of Ocular Fundus Diseases; Shanghai Engineering Center for Visual Science and Photomedicine; Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China.
Neural Regen Res. 2024 Jul 29;21(1):406-16. doi: 10.4103/NRR.NRR-D-23-01741.
Progressive photoreceptor cell death is one of the main pathological features of age-related macular degeneration and eventually leads to vision loss. Ferroptosis has been demonstrated to be associated with retinal degenerative diseases. However, the molecular mechanisms underlying ferroptosis and photoreceptor cell death in age-related macular degeneration remain largely unexplored. Bioinformatics and biochemical analyses in this study revealed xC-, solute carrier family 7 member 11-regulated ferroptosis as the predominant pathological process of photoreceptor cell degeneration in a light-induced dry age-related macular degeneration mouse model. This process involves the nuclear factor-erythroid factor 2-related factor 2-solute carrier family 7 member 11-glutathione peroxidase 4 signaling pathway, through which cystine depletion, iron ion accumulation, and enhanced lipid peroxidation ultimately lead to photoreceptor cell death and subsequent visual function impairment. We demonstrated that solute carrier family 7 member 11 overexpression blocked this process by inhibiting oxidative stress in vitro and in vivo. Conversely, solute carrier family 7 member 11 knockdown or the solute carrier family 7 member 11 inhibitor sulfasalazine and ferroptosis-inducing agent erastin aggravated H2O2-induced ferroptosis of 661W cells. These findings indicate solute carrier family 7 member 11 may be a potential therapeutic target for patients with retinal degenerative diseases including age-related macular degeneration.
进行性光感受器细胞死亡是年龄相关性黄斑变性的主要病理特征之一,最终导致视力丧失。铁死亡已被证明与视网膜退行性疾病有关。然而,年龄相关性黄斑变性中铁死亡和光感受器细胞死亡的分子机制在很大程度上仍未被探索。本研究中的生物信息学和生化分析表明,在光诱导的干性年龄相关性黄斑变性小鼠模型中,由溶质载体家族7成员11调节的xCT-依赖性铁死亡是光感受器细胞变性的主要病理过程。这一过程涉及核因子红细胞2相关因子2-溶质载体家族7成员11-谷胱甘肽过氧化物酶4信号通路,通过该通路,胱氨酸耗竭、铁离子积累和脂质过氧化增强最终导致光感受器细胞死亡及随后的视觉功能损害。我们证明,溶质载体家族7成员11的过表达通过在体外和体内抑制氧化应激来阻断这一过程。相反,溶质载体家族7成员11的敲低或溶质载体家族7成员11抑制剂柳氮磺胺吡啶和铁死亡诱导剂埃拉斯汀加重了H2O2诱导的661W细胞铁死亡。这些发现表明,溶质载体家族7成员11可能是包括年龄相关性黄斑变性在内的视网膜退行性疾病患者的潜在治疗靶点。